Leishmania infantum lipophosphoglycan induced-Prostaglandin E2 production in association with PPAR-γ expression via activation of Toll like receptors-1 and 2
暂无分享,去创建一个
P. Bozza | Nívea F Luz | R. Soares | A. Descoteaux | I. Ibraim | A. Carneiro | T. Araújo-Santos | P. Entringer | V. M. Borges | J. B. Lima | Milena Lázaro-Souza | F. H. Jesus-Santos | Sara de Moura Pontes
[1] N. Inestrosa,et al. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation , 2017, Biological reviews of the Cambridge Philosophical Society.
[2] F. Cunha,et al. Leishmania infantum Parasites Subvert the Host Inflammatory Response through the Adenosine A2A Receptor to Promote the Establishment of Infection , 2017, Front. Immunol..
[3] Junfeng Zhang,et al. A novel pyrazole‐containing indolizine derivative suppresses NF‐&kgr;B activation and protects against TNBS‐induced colitis via a PPAR‐&ggr;‐dependent pathway , 2017, Biochemical pharmacology.
[4] P. Volf,et al. In Vitro Inhibition of Leishmania Attachment to Sandfly Midguts and LL-5 Cells by Divalent Metal Chelators, Anti-gp63 and Phosphoglycans. , 2017, Protist.
[5] P. Bozza,et al. Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance , 2017, Scientific Reports.
[6] M. Wilson,et al. Lipid bodies accumulation in Leishmania infantum‐infected C57BL/6 macrophages , 2017, Parasite immunology.
[7] P. Bozza,et al. Resolvin D1 drives establishment of Leishmania amazonensis infection , 2017, Scientific Reports.
[8] Raju C Reddy,et al. PPAR Agonists for the Prevention and Treatment of Lung Cancer , 2017, PPAR research.
[9] M. Si-Tahar,et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection , 2017, Front. Immunol..
[10] H. Castro-Faria-Neto,et al. Schistosomal-derived lysophosphatidylcholine triggers M2 polarization of macrophages through PPARγ dependent mechanisms. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[11] A. Abdoli,et al. Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review , 2016, Pathogens and global health.
[12] A. Torrecilhas,et al. Lipophosphoglycans from Leishmania amazonensis Strains Display Immunomodulatory Properties via TLR4 and Do Not Affect Sand Fly Infection , 2016, PLoS neglected tropical diseases.
[13] Saikat Majumder,et al. Leishmania donovani-Induced Prostaglandin E2 Generation Is Critically Dependent on Host Toll-Like Receptor 2–Cytosolic Phospholipase A2 Signaling , 2016, Infection and Immunity.
[14] A. Da-Cruz,et al. Cytotoxic cell involvement in human cutaneous leishmaniasis: assessments in active disease, under therapy and after clinical cure , 2016, Parasite immunology.
[15] C. Brodskyn,et al. Degranulating Neutrophils Promote Leukotriene B4 Production by Infected Macrophages To Kill Leishmania amazonensis Parasites , 2016, The Journal of Immunology.
[16] P. Bousso,et al. Induction, Propagation, and Activity of Host Nitric Oxide: Lessons from Leishmania Infection. , 2015, Trends in parasitology.
[17] A. Weyrich,et al. A PPAR&ggr; AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS , 2015, Shock.
[18] A. Torrecilhas,et al. Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases , 2015, Journal of immunology research.
[19] J. M. Sforcin,et al. Nitric Oxide and Brazilian Propolis Combined Accelerates Tissue Repair by Modulating Cell Migration, Cytokine Production and Collagen Deposition in Experimental Leishmaniasis , 2015, PloS one.
[20] P. Bozza,et al. Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis. , 2015, The Journal of infectious diseases.
[21] G. Boons,et al. Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate? , 2015, Front. Cell. Infect. Microbiol..
[22] A. Torrecilhas,et al. Leishmania enriettii: biochemical characterisation of lipophosphoglycans (LPGs) and glycoinositolphospholipids (GIPLs) and infectivity to Cavia porcellus , 2015, Parasites & Vectors.
[23] J. C. Miranda,et al. Prostaglandin E2/Leukotriene B4 balance induced by Lutzomyia longipalpis saliva favors Leishmania infantum infection , 2014, Parasites & Vectors.
[24] Z. Qin,et al. Lipoteichoic Acid (LTA) and Lipopolysaccharides (LPS) from Periodontal Pathogenic Bacteria Facilitate Oncogenic Herpesvirus Infection within Primary Oral Cells , 2014, PloS one.
[25] U. Lopes,et al. Understanding the Mechanisms Controlling Leishmania amazonensis Infection In Vitro: The Role of LTB4 Derived From Human Neutrophils , 2014, The Journal of infectious diseases.
[26] A. Rojas-Bernabé,et al. Leishmania mexicana lipophosphoglycan activates ERK and p38 MAP kinase and induces production of proinflammatory cytokines in human macrophages through TLR2 and TLR4 , 2014, Parasitology.
[27] Marina Sergeeva,et al. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses , 2013, Neurochemistry International.
[28] A. Krasnov,et al. CpG- and LPS-activated MAPK signaling in in vitro cultured salmon (Salmo salar) mononuclear phagocytes. , 2013, Fish & shellfish immunology.
[29] J. Arthur,et al. Dectin-1 Regulates IL-10 Production via a MSK1/2 and CREB Dependent Pathway and Promotes the Induction of Regulatory Macrophage Markers , 2013, PloS one.
[30] R. Soares,et al. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages , 2013, Parasites & Vectors.
[31] V. Hernández-Ramírez,et al. PPAR Activation Induces M1 Macrophage Polarization via cPLA2-COX-2 Inhibition, Activating ROS Production against Leishmania mexicana , 2013, BioMed research international.
[32] R. Soares,et al. Glycoconjugates in New World species of Leishmania: polymorphisms in lipophosphoglycan and glycoinositolphospholipids and interaction with hosts. , 2012, Biochimica et biophysica acta.
[33] A. Descoteaux,et al. Leishmania promastigotes: building a safe niche within macrophages , 2012, Front. Cell. Inf. Microbio..
[34] M. Bozza,et al. Heme Oxygenase-1 Promotes the Persistence of Leishmania chagasi Infection , 2012, The Journal of Immunology.
[35] R. Soares,et al. Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: Modulation of Innate Immune System and Variations in Carbohydrate Structure , 2012, PLoS neglected tropical diseases.
[36] M. Chan,et al. Review Article Peroxisome Proliferator-activated Receptor-γ-mediated Polarization of Macrophages in Leishmania Infection 2. Resistance versus Susceptibility , 2022 .
[37] P. Bozza,et al. Lipid body function in eicosanoid synthesis: an update. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.
[38] P. Pimenta,et al. Leishmania infantum: Lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts. , 2011, International journal for parasitology.
[39] J. C. Miranda,et al. Lutzomyia longipalpis Saliva Triggers Lipid Body Formation and Prostaglandin E2 Production in Murine Macrophages , 2010, PLoS neglected tropical diseases.
[40] A. Ukil,et al. MAPK‐directed phosphatases preferentially regulate pro‐ and anti‐inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms , 2010, Journal of leukocyte biology.
[41] L. Gutiérrez-Kobeh,et al. Leishmania mexicana lipophosphoglycan differentially regulates PKCα‐induced oxidative burst in macrophages of BALB/c and C57BL/6 mice , 2010, Parasite immunology.
[42] L. Foster,et al. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages , 2010, Journal of Cell Science.
[43] L. Nagy,et al. Mycobacterium bovis Bacillus Calmette-Guérin Infection Induces TLR2-Dependent Peroxisome Proliferator-Activated Receptor γ Expression and Activation: Functions in Inflammation, Lipid Metabolism, and Pathogenesis1 , 2009, The Journal of Immunology.
[44] M. Chan,et al. Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model , 2008, Laboratory Investigation.
[45] C. Brodskyn,et al. Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis , 2008, Journal of leukocyte biology.
[46] Felipe F. Tuon,et al. Toll-Like Receptors and Leishmaniasis , 2007, Infection and Immunity.
[47] Frank Brombacher,et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.
[48] A. Descoteaux,et al. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon–γ‐primed macrophages , 2006, European journal of immunology.
[49] M. Peters-Golden,et al. Eicosanoids: mediators and therapeutic targets in fibrotic lung disease. , 2005, Clinical science.
[50] R. Soares,et al. Leishmania braziliensis: a novel mechanism in the lipophosphoglycan regulation during metacyclogenesis. , 2005, International journal for parasitology.
[51] R. Gazzinelli,et al. Role of the Toll/interleukin‐1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites , 2004, Immunological reviews.
[52] T. Baldwin,et al. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll‐like receptor 2 signaling , 2003, European journal of immunology.
[53] I. Becker,et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. , 2003, Molecular and biochemical parasitology.
[54] R. Vishwakarma,et al. Alkylacylglycerolipid domain of GPI molecules of Leishmania is responsible for inhibition of PKC-mediated c-fos expression Published, JLR Papers in Press, January 1, 2003. DOI 10.1194/jlr.M200296-JLR200 , 2003, Journal of Lipid Research.
[55] I. C. Almeida,et al. Leishmania chagasi: lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis. , 2002, Molecular and biochemical parasitology.
[56] A. Cunningham. Parasitic adaptive mechanisms in infection by leishmania. , 2002, Experimental and molecular pathology.
[57] M. Panaro,et al. Nitric oxide production by Leishmania-infected macrophages and modulation by cytokines and prostaglandins. , 2001, Parassitologia.
[58] J. Nájera. Malaria control: achievements, problems and strategies. , 2001, Parassitologia.
[59] S. Turco,et al. Glycoconjugate structures of parasitic protozoa. , 2001, Glycobiology.
[60] G. Feng,et al. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP , 1999, Journal of immunology.
[61] M. Ferguson,et al. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. , 1999, Journal of cell science.
[62] M. Desjardins,et al. Inhibition of Phagolysosomal Biogenesis by the Leishmania Lipophosphoglycan , 1997, The Journal of experimental medicine.
[63] I. C. Almeida,et al. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. , 1997, Journal of immunology.
[64] R. Epand,et al. Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[65] M. McConville,et al. Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan , 1995, The Journal of experimental medicine.
[66] G. Matlashewski,et al. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. , 1991, Journal of immunology.
[67] B. Ryffel,et al. Differential TLR2 downstream signaling regulates lipid metabolism and cytokine production triggered by Mycobacterium bovis BCG infection. , 2014, Biochimica et biophysica acta.
[68] A. Daugschies,et al. Eicosanoids in parasites and parasitic infections. , 2000, Advances in parasitology.